Keyphrases
ABCC1
9%
ABCG2
9%
Amines
13%
Anticancer Drugs
10%
Apigenin
16%
ATP-binding Cassette Transporter A1 (ABCA1)
10%
Breast Cancer Cells
11%
Breast Cancer Resistance Protein
16%
Cancer Cell Lines
12%
Cancer Cells
23%
Catechin
10%
Chemosensitizer
11%
Cutaneous Leishmaniasis
9%
Cytotoxicity
11%
Doxorubicin
11%
Drug Accumulation
10%
Drug Resistance
40%
EC50
18%
Epigallocatechin Gallate
10%
Flavonoid Monomer
68%
Flavonoids
32%
Fruit Extract
14%
Gleditsia Sinensis
18%
Homodimer
18%
IC50
13%
In Cancer
20%
Inhibitory Activity
13%
Leishmania
21%
Leishmania Enriettii
10%
Linker
9%
Modulating Activity
12%
Multidrug Resistance
49%
Multidrug Resistance in Cancer
14%
Multidrug Resistance Protein 1 (MDR1)
34%
Multidrug Resistance Reversal
23%
Overexpressing
20%
Overexpression
9%
P-glycoprotein (P-gp)
100%
P-glycoprotein Inhibitor
19%
Paclitaxel
15%
Pentamidine
11%
Pichia Pastoris
11%
Plasmodium Falciparum
9%
Protease Inhibitors
13%
Resistant Cancer Cells
9%
Structure-activity Relationship
18%
Synthetic Flavonoid
20%
Triazole
10%
Vinblastine
16%
Xenograft
17%
Pharmacology, Toxicology and Pharmaceutical Science
ABC Transporter
8%
ABCG2
27%
Acute Myeloid Leukemia
5%
Amastigote
8%
Antiproliferative Activity
5%
Apigenin
10%
Bioavailability
6%
Breast Cancer
27%
Catechin
6%
Cytotoxicity
12%
Dimer
64%
Diseases
6%
Doxorubicin
11%
Drug Resistance
48%
EC50
12%
Effusion
11%
Epicatechin
6%
Epigallocatechin
9%
Epigallocatechin Gallate
7%
Flavonoid
74%
Gleditsia
18%
Glycoprotein P Inhibitor
14%
Homodimer
9%
IC50
11%
Infection
7%
Leishmania
17%
Leishmania enriettii
5%
Leukemia
15%
Macrogol
6%
Malignant Neoplasm
64%
Multidrug Resistance
71%
Multidrug Resistance Protein 1
15%
Natural Product
10%
Neoplasm
14%
P-Glycoprotein
49%
Paclitaxel
25%
Pentamidine
11%
Pharmacokinetics
6%
Polyphenol
9%
Proteasome
8%
Proteasome Inhibitor
9%
Protozoon
5%
Skin Leishmaniasis
9%
Solid Malignant Neoplasm
7%
Structure Activity Relationship
23%
Synapsin I
8%
Triazole
10%
Verapamil
8%
Vinblastine
8%
Vincristine
7%